Transition to Adulthood Through Coaching and Empowerment in Rheumatology (TRACER)
Primary Purpose
Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Dermatomyositis
Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Transition coaching
Sponsored by
About this trial
This is an interventional supportive care trial for Juvenile Idiopathic Arthritis focused on measuring transition care, transition coaching
Eligibility Criteria
Inclusion Criteria:
- Patient with pediatic-onset rheumatic disease
- At their last paediatric rheumatology appointment prior to transferring to adult rheumatology care
- Able to communicate in English
- Have a phone or device capable of participating in video conference
- Available over the next 8 months
Exclusion Criteria:
- Cognitive impairment preventing participation in individualized education sessions (as determined by medical staff)
Sites / Locations
- McMaster Children's HospitalRecruiting
- Children's Hospital at London Health Sciences CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Standard care - control
Transition coaching - experimental
Arm Description
Standard of care, appointments with adult rheumatology
Participants will receive 8 transition coaching sessions (1/month) in addition to standard care
Outcomes
Primary Outcome Measures
Consent rate
% of patients approached who consent to the study
Enrolment from non-primary site
% of patients enrolled from non-primary site
Virtual session attendance
% of transition coaching sessions attended
Outcome measure completion
% of outcome assessments completed at 8 months (end of transition coach invention)
Missing data
% of missing data
Secondary Outcome Measures
Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire
Descriptive statistics of PROMIS questionnaire (person-centered measures to assess how people feel and function) results at baseline, 8 months and 11 months, between the two groups.
Physician Global Assessment (PGA)
Descriptive statistics of physical global assessment at baseline and at subsequent follow-up, between the two groups. Physician Global Assessment refers to MD assessment of disease activity and is rated between 0 (no disease activity) and 10 (most active disease).
Active joint count
Descriptive statistics of active joint count (joints with evidence of active inflammation - including swelling, tenderness, loss of ROM) at baseline and at subsequent follow-up, between the two groups
Global function/quality of life
Descriptive statistics of PedsQL (Paediatric Quality of Life Inventory) 4.0 Generic Core Scales Young Adult Version questionnaire results at baseline, 8 months and 11 months, between the two groups.
Full Information
NCT ID
NCT05545839
First Posted
September 13, 2022
Last Updated
March 16, 2023
Sponsor
McMaster University
Collaborators
Western University
1. Study Identification
Unique Protocol Identification Number
NCT05545839
Brief Title
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
Acronym
TRACER
Official Title
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, A Feasibility Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 17, 2022 (Actual)
Primary Completion Date
April 2025 (Anticipated)
Study Completion Date
April 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McMaster University
Collaborators
Western University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
TRACER is a study aiming to investigate the feasibility of transition coaching sessions for patients moving from paediatric to adult rheumatology care.
Detailed Description
TRACER is a feasibility study investigating transition coaching for patients with rheumatic disease transferring from paediatric to adult rheumatology care. This is a vulnerable time in the patients' care and life as they are assuming more responsibility for their health and undergoing significant life transitions. There is risk for increased morbidity and mortality around this time if the patient are not well supported and if they do not stay engaged with care. This intervention aim to provide self-efficacy, self-management, coping skills and support to patients making the transition. This study aims to assess the feasibility of conducting a multi-centre randomized trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Dermatomyositis, Juvenile Psoriatic Arthritis, Autoinflammatory Disease, Autoimmune Diseases, Lupus Erythematosus
Keywords
transition care, transition coaching
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
133 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard care - control
Arm Type
No Intervention
Arm Description
Standard of care, appointments with adult rheumatology
Arm Title
Transition coaching - experimental
Arm Type
Experimental
Arm Description
Participants will receive 8 transition coaching sessions (1/month) in addition to standard care
Intervention Type
Behavioral
Intervention Name(s)
Transition coaching
Intervention Description
Transition coaching sessions (8 sessions), covering paediatric to adult care, self-advocacy, medication management, general health, lifestyle and behaviours, future planning, screening for mood disorders and coping skills.
Primary Outcome Measure Information:
Title
Consent rate
Description
% of patients approached who consent to the study
Time Frame
19 month recruitment period
Title
Enrolment from non-primary site
Description
% of patients enrolled from non-primary site
Time Frame
19 month
Title
Virtual session attendance
Description
% of transition coaching sessions attended
Time Frame
3 year study period
Title
Outcome measure completion
Description
% of outcome assessments completed at 8 months (end of transition coach invention)
Time Frame
3 year study period
Title
Missing data
Description
% of missing data
Time Frame
3 year study period
Secondary Outcome Measure Information:
Title
Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire
Description
Descriptive statistics of PROMIS questionnaire (person-centered measures to assess how people feel and function) results at baseline, 8 months and 11 months, between the two groups.
Time Frame
3 year study period
Title
Physician Global Assessment (PGA)
Description
Descriptive statistics of physical global assessment at baseline and at subsequent follow-up, between the two groups. Physician Global Assessment refers to MD assessment of disease activity and is rated between 0 (no disease activity) and 10 (most active disease).
Time Frame
3 year study period
Title
Active joint count
Description
Descriptive statistics of active joint count (joints with evidence of active inflammation - including swelling, tenderness, loss of ROM) at baseline and at subsequent follow-up, between the two groups
Time Frame
3 year study period
Title
Global function/quality of life
Description
Descriptive statistics of PedsQL (Paediatric Quality of Life Inventory) 4.0 Generic Core Scales Young Adult Version questionnaire results at baseline, 8 months and 11 months, between the two groups.
Time Frame
3 year study period
10. Eligibility
Sex
All
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient with pediatic-onset rheumatic disease
At their last paediatric rheumatology appointment prior to transferring to adult rheumatology care
Able to communicate in English
Have a phone or device capable of participating in video conference
Available over the next 8 months
Exclusion Criteria:
Cognitive impairment preventing participation in individualized education sessions (as determined by medical staff)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michelle Batthish, MD
Phone
1-905-521-2100
Ext
75382
Email
batthim@mcmaster.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michelle Batthish, MD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster Children's Hospital
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 3Z5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michelle Batthish, MD
Phone
1-905-521-2100
Ext
75382
Email
batthim@mcmaster.ca
Facility Name
Children's Hospital at London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roberta Berard, MD
Phone
1-519-685-8500
Ext
58266
Email
roberta.berard@lhsc.on.ca
12. IPD Sharing Statement
Learn more about this trial
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
We'll reach out to this number within 24 hrs